会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Porphyrins and metalloporphyrins for inhibiting heme iron uptake
    • 卟啉和金属卟啉抑制血红素摄取
    • US20040254155A1
    • 2004-12-16
    • US10859810
    • 2004-06-03
    • Jerry C. Bommer
    • A61K031/555
    • A61K31/555A61K31/409
    • The present invention provides a class of porphyrins and metal chelated porphyrins for use as inhibitors of heme iron uptake. The porphyrin/metal chelated porphyrin molecules of the invention are tetra-positively charged porphyrins based on meso-tetra(4-pyridyl)porphines. Several such agents are shown herein to cause inhibition of iron uptake in vivo and in vitro. The invention further provides therapeutic compositions including the porphyrins and/or metalloporphyrins of the invention. In addition, methods of inhibition of heme iron uptake in vivo are taught, as well as methods of treatment of diseases characterized by iron-overload. These methods include the administration of a porphyrin or metalloporphyrin in a therapeutic composition of the invention to prevent uptake of heme iron, thus preventing replenishment of a patient's iron stores.
    • 本发明提供了一类用作血红素铁摄取抑制剂的卟啉和金属螯合卟啉。 本发明的卟啉/金属螯合卟啉分子是基于内消旋 - 四(4-吡啶基)卟吩的四正电荷卟啉。 本文显示了几种这样的试剂以在体内和体外诱导铁吸收的抑制。 本发明进一步提供包含本发明的卟啉和/或金属卟啉的治疗组合物。 此外,还教导了在体内抑制血红素铁吸收的方法,以及治疗以铁过载为特征的疾病的方法。 这些方法包括在本发明的治疗组合物中施用卟啉或金属卟啉以防止血红素铁的吸收,从而防止补充患者的铁存储。
    • 8. 发明申请
    • Antimicrobial compositions
    • 抗微生物组合物
    • US20040171600A1
    • 2004-09-02
    • US10469772
    • 2003-09-04
    • Toshimasa OhnishiIkuya Tanaka
    • A61K031/555A61K031/549A61K031/53A61K031/444
    • A01N43/88A01N59/20A01N59/16A01N47/12A01N47/04A01N43/80A01N43/70A01N43/40A01N37/34A01N31/16A01N2300/00
    • This invention concerns antimicrobial compositions that are useful for industrial applications. More specifically, it concerns antimicrobial compositions that, by combining 3-benzonullbnullthiene-2-yl-5,6-dihydro-1,4,2-oxathiazine-4-oxide and one or more of 1-nullnull(3-iodo-2-propynyl)oxynullmethoxynull-4-methoxy benzene, 1-chloro-4-nullnull(3-iodo-2-propynyl)oxynullmethoxynullbenzene, Zinc 2-pyridine thiol-1-oxide, Copper 2-pyridine thiol-1-oxide, 2-pyridine thiol-1-oxide sodium salt, 2,2-dithio-bis(pyridine-1-oxide), 2-methylthio-4-t-butyl amino-6-cyclopropyl amino-s-triazine, 3-iodo-2-propynyl butylcarbamate (IPBC), 2-(n-octyl)-3(2H)-isothiazolone (OIT), 4,5-dichloro-2-(n-octyl)-3(2H)-isothiazolone (DCOIT), 2,4,5,6-tetrachloro-1,3-benzenedicarbonitrile (chlorothalonil), 1,1-dichloro-N-null(dimethylamino)sulfonylnull-1-fluoro-N-phenyl-methanesulfenamide (dichlofluanid), or 1,1-dichloro-N-null(dimethylamino)sulfonylnull-1-fluoro-N-(4-methylphenyl)-methanesulfenamide (tolylfluanid) have the synergistic effect of these compounds.
    • 本发明涉及可用于工业应用的抗微生物组合物。 更具体地说,它涉及通过将3-苯并[b]噻吩-2-基-5,6-二氢-1,4,2-氧噻嗪-4-氧化物与一个或多个1 - [[( 3-碘-2-丙炔基)氧基]甲氧基] -4-甲氧基苯,1-氯-4 - [[(3-碘-2-丙炔基)氧基]甲氧基]苯,2-吡啶硫醇-1-氧化物 ,2-吡啶硫醇-1-氧化铜,2-吡啶硫醇-1-氧化物钠盐,2,2-二硫代双(吡啶-1-氧化物),2-甲硫基-4-叔丁基氨基-6- 环丙基氨基-s-三嗪,3-碘-2-丙炔基丁基氨基甲酸酯(IPBC),2-(正辛基)-3(2H) - 异噻唑酮(OIT),4,5-二氯-2-(正辛基) -3(2H) - 异噻唑酮(DCOIT),2,4,5,6-四氯-1,3-苯二甲腈(百菌清),1,1-二氯-N - [(二甲基氨基)磺酰基] -1-氟-N - 苯基 - 甲磺酰胺(二氯氟烷)或1,1-二氯-N - [(二甲基氨基)磺酰基] -1-氟-N-(4-甲基苯基) - 甲磺酰胺(甲苯基氟烷)具有这些化合物的协同作用。